Evidence map›Paper›PMID 38008448›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection during Sirolimus Therapy.

Atsushi Yanagisawa, Takayuki Takimoto, Yu Kurahara, Kazunari Tsuyuguchi, Shiomi Yoshida, Masaki Hirose, Yoshikazu Inoue, Toru Arai

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Atsushi YanagisawaDepartment of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
Takayuki TakimotoDepartment of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
Yu KuraharaClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
Kazunari TsuyuguchiClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
Shiomi YoshidaClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
Masaki HiroseClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
Yoshikazu InoueClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
Toru AraiClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.
NHO Kinki Chuo Chest Medical Center · JPFukujuji Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among nontuberculous mycobacterial pulmonary diseases (NTM-PDs), Mycobacterium abscessus species pulmonary disease (MABS-PD) is one of the most severe and intractable infections. We herein report a 45-year-old woman with advanced lymphangioleiomyomatosis (LAM) who developed MABS-PD while undergoing sirolimus therapy. MABS-PD was immediately controlled using antibiotic therapy, although the patient's lung transplant registration was significantly delayed. To our knowledge, this is the first case report on the development of NTM-PD in a patient with LAM before lung transplantation. This case suggests that the early diagnosis and optimal treatment of NTM-PD are crucial in patients with advanced LAM.

Indexed as

LymphangioleiomyomatosisMycobacterium abscessusMycobacterium Infections, NontuberculousSirolimusAnti-Bacterial AgentsFemaleHumansLung TransplantationMiddle AgedAnti-Bacterial AgentsSirolimuslymphangioleiomyomatosisMycobacterium abscessus speciesnontuberculous mycobacterial pulmonary diseasesirolimus

Identifiers

PMID38008448
PMCPMC11309859
OpenAlexW4389033809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.